Skip to content

Symmcora® Long-term Bidirectional Barbed Suture for Anastomosis in Patients Undergoing Robot Assisted Radical Prostatectomy

Prospective, Multicenter, Single-arm Study on the Performance of Symmcora® Long-term Bidirectional Barbed Suture for Vesicourethral Anastomosis in Patients Undergoing Robot Assisted Radical Prostatectomy.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06055946
Acronym
BARVANA LONG
Enrollment
70
Registered
2023-09-28
Start date
2023-11-07
Completion date
2025-05-19
Last updated
2025-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

robot assisted radical prostatectomy, barbed suture

Brief summary

The aim of this observational study is to show the superiority of the bidirectional barbed suture (Symmcora® Longterm) in terms of time to perform the vesicourethral anastomosis after robot assisted radical prostatectomy compared to the available literature data, without an increase in the complication rate.

Interventions

Adult male patients undergoing elective robotic assisted radical prostatectomy.will be included in the study

Sponsors

B.Braun Surgical SA
CollaboratorINDUSTRY
Aesculap AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male patients undergoing an elective robotic assisted radical prostatectomy * Written informed consent * Age ≥ 18years

Exclusion criteria

* Emergency surgery * History of chronic steroid use * Previous prostatic surgery * Previous radiotherapy or brachytherapy * Patients with hypersensitivity or allergy to the suture material. * Participation in another study * Non-compliant patient (dementia etc)

Design outcomes

Primary

MeasureTime frameDescription
Time to perform the vesicourethral anastomosisintraoperativelyTime to perform the vesicourethral anastomosis using a stopwatch. Time starts when the needle passes the first time the tissue and ends after completion of the anastomosis. Completion of the anastomosis is defined by the last cut of the thread.

Secondary

MeasureTime frameDescription
Anastomotic leak rate until 6 months postoperativelyup to 6 months after surgeryCumulative number of anastomotic leaks
Amount of estimate blood loss (EBL)intraoperativelyBlood loss is estimated by the amount of intraoperatively needed transfusion
Transfusion rateat discharge from hospital (approximately 5-10 days after surgery)Amount of transfused blood, Calculated by multiplication of the number of bags needed and the volume in ml per bag
Urinary retentionat 6 weeks postoperativelyUrinary retention is an inability to completely empty the bladder
Urinary fistula rateuntil 6 months postoperativelyA urogenital fistula is an abnormal tract that exists between the urinary tract and bladder, ureters, or urethra. A urogenital fistula can occur between any of the organs and structures of the pelvic region. A fistula allows urine to continually exit through and out the urogenital tract.
Bladder neck contracture rateuntil 6 months postoperativelyCumulative rate of patients with a complication related to the bladder neck contracture
Urinary stone formation rateuntil 6 months postoperativelyCumulative rate of patients with a complication related to urinary stone formation
Rate of other complicationsuntil 6 months postoperativelyCumulative rate of patients with any other complication (infection, embolization, peritonitis, ileus, etc.)
Operation consola timeintraoperativelyTime to perform the intervention from first cut to last cut of the last thread. The time is measured using a stopwatch.
Development of International prostate symptom score (IPSS) compared to baselinePreoperatively (Baseline), 6 weeks, 3 months and 6 months postoperatively.The International prostate symptom score (IPSS) questionnaire has seven questions, which are used to evaluate storage and voiding symptoms. The patient is given five options for the first seven questions and each option indicates severity of that symptom. The total score ranges from 0 to 35 and Lower Urinary Tract Symptoms (LUTS) are classified as mild to severe depending on the total score. Patients having a total score ≤7 are classified as having mild symptoms, scores from 8 to 19 are classified as moderate symptoms, and symptom scores ≥20 are classified as severe symptoms.
Comparison of Prostate Specific Antigen (PSA) at screening and 6 weeks after surgery.at screening and 6 weeks after surgery.PSA response will be measured as the change of serum PSA in ng/mL between preoperative / screening examination and at follow-up 6 weeks after surgery
Time to perform the Rocco stitchintraoperativelyTime to perform the modified Rocco stitch: After prostate extirpation, the free edge of the Denonvillier fascia is approximated to the posterior rhabdosphincter/median raphe using a running suture. Then, the Denonvilliers' fascia is fixated to the posterior wall of the bladder, which reduces tension in the anastomosis and provides pelvic support to the bladder neck. The time is measured using a stopwatch.
Length of postoperative stayuntil discharge (approximately 5-10 days postoperatively)Number of days from surgery till patient is discharged from hospital
Catheterization durationuntil first follow-up (6 weeks postoperatively)Number of days from surgery till catheter was finally removed
Early continence6 weeks postoperativelyDays after catheter was finally removed to complete continence
Development of continence by 24-h pad testat 3 months and 6 months postoperatively.The 24-hour pad test is used as an objective diagnostic method for the assessment of post prostatectomy stress urinary incontinence. Pads are weighed before and after use and the amount of urine is measured.
Development of Erectile Function compared to baselinePreoperatively (Baseline), 6 weeks, 3 months and 6 months postoperatively.Erectile Function measured by International Index of Erectile Function (IIEF-5). The International Index of Erectile Function-5 (IIEF-5) is an five-item Index developed to diagnose the presence and severity of erectile dysfunction (ED). The five items are based on ability to identify the presence or absence of ED and on adherence to the National Institute of Health's definition of ED. These items focus on erectile function and intercourse satisfaction. The items are rated on a scale from 1-5 (e.g., 1=Very low to 5=Very high; 1=Almost never/never to 5=Almost always/always; 1=Extremely difficult to 5=Not difficult). The IIEF-5 score is the sum of questions 1 to 5 (Scores range from 5-25). ED was classified into five severity levels, ranging from none (22-25) through severe (5-7).

Other

MeasureTime frameDescription
Assessment of the intraoperative handling of the Symmcora® Long bidirectionalafter inclusion of the last patientHandling of the suture is assessed for every participating surgeon once after inclusion of the last patient. Handling is measured in 16 dimensions + overall impression with five evaluation levels (excellent, very good, good, satisfied, poor)
Assessment of the intraoperative handling of the Symmcora® Mid Unidirectionalafter inclusion of the last patientHandling of the suture is assessed for every participating surgeon once after inclusion of the last patient. Handling is measured in 13 dimensions + overall impression with five evaluation levels (excellent, very good, good, satisfied, poor)

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026